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Axons have an Achilles’ heel that antibodies 
can attack to cause multiple sclerosis (MS), 
Mathey et al. show on page 2363.
MS is triggered when T cells breach the 
blood–brain barrier and produce inflammatory 
cytokines that activate myelin-scavenging 
macrophages, causing damage to the myelin 
sheath. Myelin-specific antibodies that enter 
the brain in the T cells’ wake enhance the 
destruction of the sheath and exacerbate disease. 
Researchers have blamed this myelin destruc-
tion for the neurological problems of patients 
with MS. But in some patients, damage 
happens not just to the myelin, but to the 
axons themselves. Because myelin can be 
replaced, axon damage is now considered to 
be the cause of permanent disability.
Mathey et al. now find that some MS 
patients have antibodies that attack the parts 
of axons known as the nodes of Ranvier. 
These nodes must be myelin free to allow 
clusters of voltage-gated ion channels to 
propagate action potentials.
The newly identified antibodies recognized 
a structural node protein called neurofascin-186 
(NF-186). The antibodies interrupted neuro-
transmission in tissue sections and worsened 
disease symptoms by damaging axons in a 
rat model of MS.
Higher levels of these antibodies were 
found in patients who have a particularly 
  degenerative version of the disease. The study 
included only a small number of patients, but 
if the trend continues in larger groups, the 
authors will then test whether getting rid of 
antibody-producing B cells or filtering the 
antibodies out of the patients’ blood might 
halt disease progression. 
Buttoned-up vessels
A study by Baluk et al. (page 2349) reveals how the organization of junc-
tional proteins might keep endothelial cells in lymphatic vessels but-
toned up but still allow fluid and cells to enter.
Lymph flows through a network that starts out as tiny vessels and 
then widens into collecting ducts. But how lymph gets from the blood 
into lymph vessels through the endothelial barrier is unclear. One model 
suggests that endothelial cells lack junctions and thus glide apart under 
mechanical stress. Another proposes that junctions break down to permit 
fluid entry and then reseal.
Baluk et al. did not favor either idea, as junctions are required to 
maintain vessel structure, and their breakdown and reconstruction 
spell excessive wear and tear on the vessel. The team traced the 
expression of junctional proteins in lymphatic vessels in mouse airways 
and found that the proteins formed continuous zipper-like structures 
in collecting ducts. In the tiny vessel entryways, however, they were 
organized into button-like clumps at 
the corners of adjacent endothelial cells.
The flaps between the buttons 
probably allow fluid to enter, but the 
authors are not sure whether cells also 
crawl in through these openings. In 
the lymph networks of mice whose 
airways were inflamed, leukocytes sidled 
alongside the buttoned openings 
rather than the zippered ends. But the 
team is yet to catch cells in the act of 
creeping through. 
T cells raise the tension
The price of immunity might be high blood pressure, as data from Guzik et al. 
(page 2449) suggest.
High blood pressure—or hypertension—is triggered by angiotensin II. 
This hormone instructs the kidneys to retain salt and the brain to release 
stress hormones. It also activates oxidases that generate free radicals, which 
narrow blood vessels and cause plaques to grow and harden the arteries.
Recent evidence suggests that angiotensin II might also get the immune 
system into the tension-raising act. Patients with immune systems weakened by 
immunosuppressive drugs or HIV infection have low blood pressure, which can 
skyrocket when they go off the drugs or start taking antiviral medications. One 
set of lymphocytes, the T cells, are the likeliest culprits, as they bear angiotensin 
II receptors and the same dangerous free radical–generating enzymes.
Guzik et al. now find that angiotensin II activates T cells to raise blood 
pressure. Mice that lack lymphocytes failed to develop hypertension after 
angiotensin II injection unless T cells were put back in. The hormone, they found, 
increased the T cells’ ability to attach to and infiltrate blood vessel walls. The 
cells congregated in the underlying fatty tissue and secreted the inflammatory 
cytokine tumor necrosis factor (TNF), which further activates free radical 
production in the surrounding cells. Blocking TNF blunted hypertension.
The authors propose that T cells infiltrating the kidney and the brain 
might also amplify angiotensin II’s damaging effects in these organs. 
A junctional protein (red) clumps 
(arrows) at lymph vessel entryways 
but is continuous (arrowheads) in 
the lower collecting ducts.
Antibodies (green) against neurofascin bind to the 
unmyelinated nodes of Ranvier (blue) in axons (red).